This company has been acquired
Salud financiera de hoja de balance de Coeptis Therapeutics
Salud financiera controles de criterios 1/6
Información clave
185.0%
Ratio deuda-patrimonio
US$3.81m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$2.38m |
| Patrimonio | US$2.06m |
| Total pasivo | US$4.46m |
| Activos totales | US$6.52m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: COEP's short term assets ($2.4M) do not cover its short term liabilities ($4.3M).
Pasivo a largo plazo: COEP's short term assets ($2.4M) exceed its long term liabilities ($206.4K).
Historial y análisis de deuda-patrimonio
Nivel de deuda: COEP's net debt to equity ratio (69.6%) is considered high.
Reducción de la deuda: Insufficient data to determine if COEP's debt to equity ratio has reduced over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: COEP has less than a year of cash runway based on its current free cash flow.
Pronóstico de cash runway: COEP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 43.5% each year